Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115433) titled 'Human bioequivalence study of Dolutegravir Sodium Tablets' on Dec. 26, 2025.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Deyang City People's Hospital
Condition:
Infected with the human immunodeficiency virus (HIV)
Intervention:
Group B:Take the reference preparation before taking the test preparation under fasting conditions, the washing period is 7 days.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-26
Target Sample Size: Group B:24;Group A:24;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj....